As expected (6, –, 8, 11), globally IFN-γR2−/− mice were completely resistant to the development of ECM (Fig. 1B to D), whereas almost 100% of WT mice developed signs of late-stage ECM, typically on day 7 of infection (Fig. 1C and D). The gene discussed is IFNGR2; the disease is infection.